These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29263038)

  • 1. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
    Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
    Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
    Yang P; Wei J; Li W; He F; Zeng S; Zhang T; Sun Z; Cao J
    Biotechnol Lett; 2016 Jun; 38(6):1043-7. PubMed ID: 26965150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
    Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
    Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
    Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
    Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased phosphorylation of 4E‑binding protein 1 predicts poor prognosis for patients with colorectal cancer.
    Miao Y; Chen L; Shi C; Fan R; Chen P; Liu H; Xia A; Qian H
    Mol Med Rep; 2017 May; 15(5):3099-3104. PubMed ID: 28339030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
    Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
    Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.
    Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY
    Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
    Yang B; Gao J; Rao Z; Shen Q
    Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.
    Matsuda M; Sentani K; Noguchi T; Hinoi T; Okajima M; Matsusaki K; Sakamoto N; Anami K; Naito Y; Oue N; Yasui W
    Pathol Int; 2010 Oct; 60(10):673-80. PubMed ID: 20846265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.